315 related articles for article (PubMed ID: 33680923)
1.
Jiménez-Reinoso A; Nehme-Álvarez D; Domínguez-Alonso C; Álvarez-Vallina L
Front Oncol; 2020; 10():593848. PubMed ID: 33680923
[TBL] [Abstract][Full Text] [Related]
2. Adoptive T cell therapy for solid tumors: current landscape and future challenges.
Albarrán V; San Román M; Pozas J; Chamorro J; Rosero DI; Guerrero P; Calvo JC; González C; García de Quevedo C; Pérez de Aguado P; Moreno J; Cortés A; Soria A
Front Immunol; 2024; 15():1352805. PubMed ID: 38550594
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Kazemi MH; Sadri M; Najafi A; Rahimi A; Baghernejadan Z; Khorramdelazad H; Falak R
Front Immunol; 2022; 13():1018962. PubMed ID: 36389779
[TBL] [Abstract][Full Text] [Related]
4. Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
Li B
Front Immunol; 2022; 13():973881. PubMed ID: 36341370
[TBL] [Abstract][Full Text] [Related]
5. Adoptive Cell Therapy for Metastatic Melanoma.
Merhavi-Shoham E; Itzhaki O; Markel G; Schachter J; Besser MJ
Cancer J; 2017; 23(1):48-53. PubMed ID: 28114254
[TBL] [Abstract][Full Text] [Related]
6. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions.
Granhøj JS; Witness Præst Jensen A; Presti M; Met Ö; Svane IM; Donia M
Expert Opin Biol Ther; 2022 May; 22(5):627-641. PubMed ID: 35414331
[TBL] [Abstract][Full Text] [Related]
8. Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs.
Forsberg EMV; Riise R; Saellström S; Karlsson J; Alsén S; Bucher V; Hemminki AE; Olofsson Bagge R; Ny L; Nilsson LM; Rönnberg H; Nilsson JA
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765608
[TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic.
Duong CP; Yong CS; Kershaw MH; Slaney CY; Darcy PK
Mol Immunol; 2015 Oct; 67(2 Pt A):46-57. PubMed ID: 25595028
[TBL] [Abstract][Full Text] [Related]
10. Adoptive tumor infiltrating lymphocyte transfer as personalized immunotherapy.
Diaz-Cano I; Paz-Ares L; Otano I
Int Rev Cell Mol Biol; 2022; 370():163-192. PubMed ID: 35798505
[TBL] [Abstract][Full Text] [Related]
11. Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead.
Kirtane K; Elmariah H; Chung CH; Abate-Daga D
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301811
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis.
Qayoom H; Sofi S; Mir MA
Immunol Res; 2023 Aug; 71(4):588-599. PubMed ID: 37004645
[TBL] [Abstract][Full Text] [Related]
13. Tumor infiltrating lymphocytes in ovarian cancer.
Santoiemma PP; Powell DJ
Cancer Biol Ther; 2015; 16(6):807-20. PubMed ID: 25894333
[TBL] [Abstract][Full Text] [Related]
14. Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies.
Mayor P; Starbuck K; Zsiros E
Gynecol Oncol; 2018 Aug; 150(2):361-369. PubMed ID: 29803316
[TBL] [Abstract][Full Text] [Related]
15. [Function of tumor infiltrating lymphocytes in solid tumors - a review].
Bai S; Yang X; Zhang N; Zhang F; Shen Z; Yang N; Zhang W; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2019 Dec; 35(12):2308-2325. PubMed ID: 31880138
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions.
Radvanyi LG
Cancer J; 2015; 21(6):450-64. PubMed ID: 26588676
[TBL] [Abstract][Full Text] [Related]
17. Tumor immunity: A brief overview of tumor‑infiltrating immune cells and research advances into tumor‑infiltrating lymphocytes in gynecological malignancies (Review).
Wang ZT; Deng ZM; Dai FF; Yuan MQ; Liu SY; Li BS; Cheng YX
Exp Ther Med; 2024 Apr; 27(4):166. PubMed ID: 38476909
[TBL] [Abstract][Full Text] [Related]
18. Adoptive Cell Therapy-Harnessing Antigen-Specific T Cells to Target Solid Tumours.
Chruściel E; Urban-Wójciuk Z; Arcimowicz Ł; Kurkowiak M; Kowalski J; Gliwiński M; Marjański T; Rzyman W; Biernat W; Dziadziuszko R; Montesano C; Bernardini R; Marek-Trzonkowska N
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183246
[TBL] [Abstract][Full Text] [Related]
19. Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.
Lee HJ; Kim YA; Sim CK; Heo SH; Song IH; Park HS; Park SY; Bang WS; Park IA; Lee M; Lee JH; Cho YS; Chang S; Jung J; Kim J; Lee SB; Kim SY; Lee MS; Gong G
Oncotarget; 2017 Dec; 8(69):113345-113359. PubMed ID: 29371915
[TBL] [Abstract][Full Text] [Related]
20. Improving the efficacy and safety of engineered T cell therapy for cancer.
Shi H; Liu L; Wang Z
Cancer Lett; 2013 Jan; 328(2):191-7. PubMed ID: 23022475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
